Senior Director, Clinical Science — Thoracic Oncology

Merck & Co.; Upper Gwynedd Township (Montgomery County); Hybrid; USD 210,000 - 331,000; Full time

Job summary

Merck & Co., Inc. is seeking a Senior Director, Clinical Science, Thoracic Oncology to provide strategic leadership across multiple thoracic oncology studies and assets.

You will shape development strategy, guide data interpretation, and align cross-functional teams to ensure consistent scientific standards and decision making. The role requires deep knowledge of thoracic oncology biology, treatment landscapes, and clinically meaningful endpoints.

Qualifications

• Significant experience in Clinical Development, Clinical Science, or related field within pharma/biotech.
• Demonstrated leadership across multiple studies, programs, or assets.
• Deep therapeutic area expertise in oncology and evidence-driven decision making.
• Experience leading cross-functional teams in a matrix environment.

Responsibilities

• Provide senior Clinical Science leadership across Thoracic Oncology studies and programs.
• Guide protocol development, endpoint selection, and biomarker strategy discussions.
• Partner with cross-functional leaders to align Clinical Science activities with program goals.
• Standardize scientific practices and drive innovation in data review and analytics.
• Support governance discussions and senior leadership communications with scientific insights.

Skills

Clinical Development

Clinical Science

Oncology

Leadership

Matrix Management

Budget Management

Education

Advanced scientific or healthcare degree

Master's degree

Bachelor's degree

Job description

Merck & Co., Inc. is seeking a Senior Director, Clinical Science, Thoracic Oncology to provide strategic leadership across multiple thoracic oncology studies and assets.

You will shape development strategy, guide data interpretation, and align cross-functional teams to ensure consistent scientific standards and decision making. The role requires deep knowledge of thoracic oncology biology, treatment landscapes, and clinically meaningful endpoints.